FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096370984> ?p ?o ?g. }

• W3096370984 endingPage "1095" @default.
• W3096370984 startingPage "1084" @default.
• W3096370984 abstract "Abstract Background The role of adjuvant epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) is not clear in early‐stage nonsmall‐cell lung cancer (NSCLC) patients. This meta‐analysis aims to compare the efficacy and safety of EGFR‐TKIs as adjuvant therapy with chemotherapy or placebo in NSCLC patients harboring EGFR mutations. Patients and Methods Pubmed, Embase, and Cochrane databases were searched for randomized controlled trials. The hazard ratio (HR) of disease‐free survival (DFS) and overall survival (OS) as well as the risk ratio (RR) of severe adverse events were merged. Results Seven articles from five studies from 1843 records, a total of 1227 patients, were included in the analysis. The HR for DFS was 0.38 (95% confidence interval [CI] 0.22–0.63), in favor of EGFR‐TKIs. However, no significant benefit of OS was seen (HR = 0.61, 95% CI 0.31–1.22). Treatment benefit was more pronounced in patients with advanced disease stage and longer duration of medication, EGFR exon 19 deletion mutation, and treatment with third‐generation EGFR‐TKIs. Adjuvant targeted therapy may cause few adverse events compared with chemotherapy (RR = 0.28, 95% CI 0.09–0.94). The possibility of severe adverse events for the first‐generation drugs was significantly lower than for third‐generation drugs. Conclusion In EGFR mutation‐positive patients with stage IB–IIIA NSCLC, compared with adjuvant chemotherapy or placebo, adjuvant EGFR‐TKIs should effectively improve the patient's DFS, but not effectively improve OS. Disease stage, treatment duration, mutation types, and therapeutic drugs could affect the degree of benefit. Adjuvant EGFR‐TKIs had more favorable tolerability than chemotherapy, especially with the usage of first‐generation drugs." @default.
• W3096370984 created "2020-11-09" @default.
• W3096370984 creator A5011293216 @default.
• W3096370984 creator A5012798427 @default.
• W3096370984 creator A5015704722 @default.
• W3096370984 creator A5036989840 @default.
• W3096370984 creator A5041358763 @default.
• W3096370984 creator A5060549116 @default.
• W3096370984 creator A5067354862 @default.
• W3096370984 creator A5072742414 @default.
• W3096370984 creator A5074781759 @default.
• W3096370984 date "2021-03-04" @default.
• W3096370984 modified "2023-10-14" @default.
• W3096370984 title "The role of <scp>EGFR‐TKIs</scp> as adjuvant therapy in <scp>EGFR mutation‐positive early‐stage NSCLC</scp> : A meta‐analysis" @default.
• W3096370984 cites W1967394241 @default.
• W3096370984 cites W1970687736 @default.
• W3096370984 cites W1994539763 @default.
• W3096370984 cites W2009775937 @default.
• W3096370984 cites W2017158584 @default.
• W3096370984 cites W2061932411 @default.
• W3096370984 cites W2088540000 @default.
• W3096370984 cites W2093667507 @default.
• W3096370984 cites W2096198395 @default.
• W3096370984 cites W2104504726 @default.
• W3096370984 cites W2116971923 @default.
• W3096370984 cites W2123873666 @default.
• W3096370984 cites W2126930838 @default.
• W3096370984 cites W2135192471 @default.
• W3096370984 cites W2152429112 @default.
• W3096370984 cites W2153405820 @default.
• W3096370984 cites W2160889088 @default.
• W3096370984 cites W2231734012 @default.
• W3096370984 cites W2305593924 @default.
• W3096370984 cites W2463124452 @default.
• W3096370984 cites W2560717039 @default.
• W3096370984 cites W2596364503 @default.
• W3096370984 cites W2607970143 @default.
• W3096370984 cites W2760639821 @default.
• W3096370984 cites W2768989095 @default.
• W3096370984 cites W2770621380 @default.
• W3096370984 cites W2770828094 @default.
• W3096370984 cites W2776226358 @default.
• W3096370984 cites W2888297236 @default.
• W3096370984 cites W2929106448 @default.
• W3096370984 cites W2947310423 @default.
• W3096370984 cites W2947467192 @default.
• W3096370984 cites W2964811642 @default.
• W3096370984 cites W2965805201 @default.
• W3096370984 cites W2990041408 @default.
• W3096370984 cites W3010920507 @default.
• W3096370984 cites W3030915148 @default.
• W3096370984 cites W3087185067 @default.
• W3096370984 cites W3087210493 @default.
• W3096370984 cites W3211488171 @default.
• W3096370984 cites W4236420271 @default.
• W3096370984 doi "https://doi.org/10.1111/1759-7714.13874" @default.
• W3096370984 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8017245" @default.
• W3096370984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33660941" @default.
• W3096370984 hasPublicationYear "2021" @default.
• W3096370984 type Work @default.
• W3096370984 sameAs 3096370984 @default.
• W3096370984 citedByCount "9" @default.
• W3096370984 countsByYear W30963709842021 @default.
• W3096370984 countsByYear W30963709842022 @default.
• W3096370984 countsByYear W30963709842023 @default.
• W3096370984 crossrefType "journal-article" @default.
• W3096370984 hasAuthorship W3096370984A5011293216 @default.
• W3096370984 hasAuthorship W3096370984A5012798427 @default.
• W3096370984 hasAuthorship W3096370984A5015704722 @default.
• W3096370984 hasAuthorship W3096370984A5036989840 @default.
• W3096370984 hasAuthorship W3096370984A5041358763 @default.
• W3096370984 hasAuthorship W3096370984A5060549116 @default.
• W3096370984 hasAuthorship W3096370984A5067354862 @default.
• W3096370984 hasAuthorship W3096370984A5072742414 @default.
• W3096370984 hasAuthorship W3096370984A5074781759 @default.
• W3096370984 hasBestOaLocation W30963709841 @default.
• W3096370984 hasConcept C126322002 @default.
• W3096370984 hasConcept C142724271 @default.
• W3096370984 hasConcept C143998085 @default.
• W3096370984 hasConcept C197934379 @default.
• W3096370984 hasConcept C204787440 @default.
• W3096370984 hasConcept C207103383 @default.
• W3096370984 hasConcept C27081682 @default.
• W3096370984 hasConcept C2776256026 @default.
• W3096370984 hasConcept C2776694085 @default.
• W3096370984 hasConcept C2777863537 @default.
• W3096370984 hasConcept C2777982462 @default.
• W3096370984 hasConcept C44249647 @default.
• W3096370984 hasConcept C71924100 @default.
• W3096370984 hasConcept C95190672 @default.
• W3096370984 hasConceptScore W3096370984C126322002 @default.
• W3096370984 hasConceptScore W3096370984C142724271 @default.
• W3096370984 hasConceptScore W3096370984C143998085 @default.
• W3096370984 hasConceptScore W3096370984C197934379 @default.
• W3096370984 hasConceptScore W3096370984C204787440 @default.
• W3096370984 hasConceptScore W3096370984C207103383 @default.
• W3096370984 hasConceptScore W3096370984C27081682 @default.
• W3096370984 hasConceptScore W3096370984C2776256026 @default.

• next